A61K 41/10
Inactivation or decontamination of a medicinal preparation prior to administration to an
Official title: Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
A61K41/10 (Inactivation or decontamination of a medicinal preparation prior to administration to an) appears on 305 US grants and 391 published applications in this corpus.
Search patents in A61K- Granted patents
- 305
- Published applications
- 391
- Assignees
- 242
- Inventors
- 809
- Latest grant
- 7 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 2 | 0 |
| 1981 | 2 | 0 |
| 1982 | 1 | 0 |
| 1983 | 4 | 0 |
| 1984 | 2 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 3 | 0 |
| 1991 | 2 | 0 |
| 1992 | 2 | 0 |
| 1993 | 4 | 0 |
| 1994 | 3 | 0 |
| 1995 | 7 | 0 |
| 1996 | 10 | 0 |
| 1997 | 12 | 0 |
| 1998 | 13 | 0 |
| 1999 | 16 | 0 |
| 2000 | 8 | 0 |
| 2001 | 14 | 4 |
| 2002 | 10 | 14 |
| 2003 | 13 | 23 |
| 2004 | 5 | 13 |
| 2005 | 4 | 14 |
| 2006 | 8 | 9 |
| 2007 | 9 | 22 |
| 2008 | 3 | 14 |
| 2009 | 3 | 11 |
| 2010 | 7 | 28 |
| 2011 | 5 | 12 |
| 2012 | 12 | 6 |
| 2013 | 5 | 12 |
| 2014 | 10 | 9 |
| 2015 | 6 | 13 |
| 2016 | 8 | 8 |
| 2017 | 5 | 20 |
| 2018 | 8 | 21 |
| 2019 | 6 | 16 |
| 2020 | 14 | 16 |
| 2021 | 9 | 11 |
| 2022 | 4 | 16 |
| 2023 | 9 | 27 |
| 2024 | 10 | 27 |
| 2025 | 13 | 13 |
| 2026 | 11 | 12 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Substituted tetrazoles as ACSS2 inhibitors7 Jul 2026US 12,673,046 B2Merck Patent GmbH
- Sterile human placental allografts and methods of making thereof9 Jun 2026US 12,648,969 B2Biostem Technologies, Inc.
- Bacterial membrane vesicles, and separation and preparation system and method therefor9 Jun 2026US 12,648,990 B2Sichuan University
- Application of bacteria in preparation of synergist for immune checkpoint inhibitor19 May 2026US 12,629,396 B2Sun Yat-Sen University Cancer Center
- Lenses for treating ocular diseases and preparation method thereof5 May 2026US 12,616,652 B2Guangdong ProCapZoom Biosciences Co., Ltd.
- Micronized compositions for wound healing prepared from human umbilical cord tissue and intact amnion-chorion tissue having an intact intermediate spongy layer positioned there between1 Oct 2026US 2026/0294982 A1Biostem Technologies, Inc.
- Sterile human placental allografts and methods of making thereof1 Oct 2026US 2026/0294983 A1Biostem Technologies, Inc.
- Sterile human placental allografts and methods of making thereof24 Sep 2026US 2026/0284121 A1Biostem Technologies, Inc.
- Ophthalmic formulation for topical use containing helenalin, 11a,13-dihydro helenalin and flavonoids from arnica montana extract and sodium hyaluronate, and use thereof by humans to treat dry eye syndrome16 Jul 2026US 2026/0199417 A1Centro De Retina Medica Y Quirurgica, S.C.
- Manufacturing of selenium disulfide compositions2 Jul 2026US 2026/0183332 A1Azura Ophthalmics Ltd.
Most cited
By later US patents
- Texaphyrin metal complexes having improved functionalization254US 5,599,923 ABoard of Regents, University of TX · 1997
- Texaphyrin compounds having improved functionalization233US 5,599,928 ABoard of Regents, The University of Texas System · 1997
- Dye treatment solution and photodynamic therapy and method of using same164US 6,251,127 B1Advanced Photodynamic Technologies, Inc. · 2001
- Apparatus and method for killing unwanted cells134US 4,395,397 ASidney Farber Cancer Institute, Inc. · 1983
- Method of inactivation of viral and bacterial blood contaminants114US 5,418,130 ACryopharm Corporation · 1995